1. A lady with NASH and choreoathetosis. Issue 5 (3rd September 2015) Authors: Ghys, C.; Kong, M.-F.; Glibert, G.; Lasser, L.; Karmali, R. Journal: Acta clinica belgica Issue: Volume 70:Issue 5(2015) Page Start: 375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Distribution of clinical risk factors for fracture in a Brussels cohort of postmenopausal women: The FRISBEE study and comparison with other major cohort studies. (December 2017) Authors: Cappelle, S.I.; Ramon, I.; Dekelver, C.; Rozenberg, S.; Baleanu, F.; Karmali, R.; Rubinstein, M.; Tondeur, M.; Moreau, M.; Paesmans, M.; Bergmann, P.; Body, J.-J. Journal: Maturitas Issue: Volume 106(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EXTENDED FOLLOW‐UP OF A PHASE I TRIAL OF IPILIMUMAB, NIVOLUMAB AND BRENTUXIMAB VEDOTIN IN RELAPSED HODGKIN LYMPHOMA: A TRIAL OF THE ECOG‐ACRIN RESEARCH GROUP (E4412). (12th June 2019) Authors: Diefenbach, C.S.; Hong, F.; Ambinder, R.; Cohen, J.; Robertson, M.; David, K.; Advani, R.; Fenske, T.; Barta, S.; Palmisano, N.; Svoboda, J.; Morgan, D.; Karmali, R.; Kahl, B.; Ansell, S. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. GSK‐3ß INHIBITOR, 9‐ING‐41 REDUCES CELL VIABILITY AND HALTS PROLIFERATION OF B‐CELL LYMPHOMA. (June 2017) Authors: Karmali, R.; Chukkapalli, V.; Pro, B.; Borgia, J.A.; Mazar, A.; Ugolkov, A.; Giles, F.J. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 400 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Intermittent hypercalcaemia and vitamin D sensitivity in Hodgkin's disease. Issue 779 (September 1990) Authors: Karmali, R.; Barker, S.; Hewison, M.; Fraher, L.; Katz, D. R.; O'Riordan, J. L. Journal: Postgraduate medical journal Issue: Volume 66:Issue 779(1990) Page Start: 757 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. MAINTENANCE RITUXIMAB IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL IN MANTLE CELL LYMPHOMA PATIENTS RESPONDING TO INDUCTION THERAPY WITH BENDAMUSTINE + RITUXIMAB (BR). (12th June 2019) Authors: Hill, B.T.; Switchenko, J.M.; Martin, P.; Churnetski, M.C.; Sawalha, Y.; Goyal, S.; Shanmugasundaram, K.; Calzada, O.; Kolla, B.; Bachanova, V.; Gerson, J.N.; Barta, S.K.; Maldonado, E.; Gordon, M.; Danilov, A.; Grover, N.S.; Mathews, S.; Burkart, M.; Karmali, R.; Ghosh, N. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. METABOLIC CHANGES ASSOCIATED WITH METFORMIN POTENTIATES ANTI‐BCL‐2 INHIBITOR, ABT‐199, AND CDK9 INHIBITOR, BAY‐1143572 AND REDUCES VIABILITY OF LYMPHOMA CELLS. (June 2017) Authors: Karmali, R.; Chukkapalli, V.; Gordon, L.I.; Borgia, J.A. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 401 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OUTCOMES FOR PATIENTS WITH MANTLE CELL LYMPHOMA EXPERIENCING FRONTLINE TREATMENT FAILURE: A MULTICENTER RETROSPECTIVE STUDY. (12th June 2019) Authors: Bond, D.A.; Switchenko, J.; Maddocks, K.; Churnetski, M.; Goyal, S.; Shanmugasundaram, K.; Calzada, O.; Kolla, B.; Bachanova, V.; Gerson, J.; Barta, S.; Hill, B.; Salwaha, Y.; Martin, P.; Maldonado, E.; Gordon, M.; Danilov, A.; Grover, N.; Mathews, S.; Burkart, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 408 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗